CA 27-29 is a blood test that tracks a protein many breast cancers shed, and a result is generally flagged high once it passes the upper edge of a fairly low normal range, at about 38 U/mL at most labs. A high number is a signal to look closer, not a diagnosis, because the same protein rises for reasons that have nothing to do with breast cancer. What usually tells doctors the most is not one reading but which way the numbers move from test to test.
The Normal Range and Where High Begins
CA 27-29 is a tumor marker, meaning a substance in the blood that can rise when certain cancers are present. Each lab prints a reference range, the span of values it considers normal, and the cutoffs are very close from lab to lab:
- Mayo Clinic Laboratories: 38.0 U/mL or lower is normal for adults.1Mayo Clinic Laboratories. Breast Carcinoma-Associated Antigen, Serum
- UMass Memorial: 38 U/mL or lower is normal.2UMass Memorial Health. CA 27-29
- Labcorp: 0 to 38.6 U/mL is normal.3Labcorp. Cancer Antigen (CA) 27.29 Information
Results are reported in units per milliliter (U/mL), a measure of how much of the protein is in your blood. Anything above your lab’s upper limit, usually about 38 U/mL, will be flagged high on your report.4UMass Memorial Health. CA 27-29 Values can differ depending on the lab’s method, so compare results from the same lab when you can.5Mayo Clinic Laboratories. Breast Carcinoma-Associated Antigen, Serum No normal range has been set for people under 18.6Mayo Clinic Laboratories. Breast Carcinoma-Associated Antigen, Serum And a high flag is not specific to cancer.7Mayo Clinic Laboratories. Breast Carcinoma-Associated Antigen, Serum
On a patient portal, the report usually shows your value, the normal range beside it, and an H flag. A result of 40 and a result of 400 get the same flag but mean very different things. Still, the size of the rise above 38 matters less than how it compares with your own earlier results. Seeing a result before your doctor calls is common, and it doesn’t mean anything urgent was found.
Small elevations just above the cutoff are common and often have harmless explanations. Much higher values raise more concern, but they still need scans to explain them. No single number on its own confirms cancer has returned.
Labs use different assay kits and calibrations, so the same blood sample can produce slightly different numbers at two labs, and the printed normal ranges differ a little for the same reason. A move from 36 at one lab to 41 at another may reflect the change in method rather than any change in your body. That is why the lab name belongs next to every result. If your care moves to a new hospital, or a different lab draws your blood, mention it when you discuss a new result so your doctor can interpret it correctly.
A result that appears on the portal before your doctor has reviewed it is a raw number without context, so it can wait for the conversation that explains it. In the meantime, write down the value, the date and the lab’s normal range, along with any recent illness, new medicines or pregnancy, so you can raise them with your care team. If you have new symptoms such as bone pain, a persistent cough or unexplained weight loss, contact your team promptly rather than waiting for a routine call. Symptoms matter whatever the number says.
What a High Result Can Mean for Breast Cancer
CA 27-29 is a loose form of a protein that sits on the surface of gland-lining cells.8PubMed. CA 27-29 in patients with breast cancer with pulmonary fibrosis Breast tumors grow from these cells, so they often make far more of it.9PubMed. CA 27-29 in patients with breast cancer with pulmonary fibrosis That is why the test is mainly used to follow known breast cancer, not to find it.10Cedars-Sinai. CA 27-29 It is not a screening test for people who don’t have a diagnosis.11University of Rochester Medical Center. CA 27-29
In people whose breast cancer had spread, the marker was raised in about 7 in 10.12PubMed. Comparison of CEA, MCA, CA 15-3 and CA 27-29 in follow-up and monitoring therapeutic response in breast cancer patients That leaves roughly 3 in 10 with spread who had a normal result, so a normal value doesn’t rule spread out. Levels were highest when cancer had spread to the liver or bones.13PubMed. Comparison of CEA, MCA, CA 15-3 and CA 27-29 in follow-up and monitoring therapeutic response in breast cancer patients They also rose, on average, about 3 months before the spread was found by other means.14PubMed. Comparison of CEA, MCA, CA 15-3 and CA 27-29 in follow-up and monitoring therapeutic response in breast cancer patients The marker can also help predict early return in women treated for breast cancer.15Mayo Clinic Laboratories. Breast Carcinoma-Associated Antigen, Serum
That 7 in 10 figure comes from people who already had spread cancer. It describes how often the test picks up known spread, not how likely a high result is to mean spread in any one person. That likelihood depends on your own history: stage at diagnosis, how long ago treatment ended, and whether you have symptoms or other conditions that raise the marker. The same number can mean different things for different people, which is why your doctor reads it against your whole history.
A normal result isn’t a full all-clear. Some cancers simply don’t release much of this protein. New bone pain still needs checking even with a normal marker, and scans, not the marker, show where cancer is.
A rise months before spread is found can prompt earlier scans, but it doesn’t say where the cancer is. Earlier detection of spread doesn’t always change treatment outcomes, which is part of the debate over routine use discussed later.
Because levels were highest with spread to the liver or bones, a very high value is more often tied to larger or more widespread disease, though that is a tendency and not a rule. Spread to some other places, such as the lung lining or lymph nodes, may release less of the protein, so the marker can sit lower even when disease is present. Since the marker cannot say where cancer is, doctors use scans of the liver, bones or chest to find it, chosen according to your symptoms.
The marker is not used to diagnose breast cancer. A lump or an abnormal mammogram is evaluated with imaging and a biopsy, which examines actual cells, and the marker cannot replace that. Early breast cancers often release too little of the protein to raise the level, so a normal result would falsely reassure someone who does have a tumor. Other conditions raise it too, so a high result in someone with no diagnosis would trigger worry and testing without pointing to breast cancer.
Other Reasons CA 27-29 Can Be High
The marker isn’t tied to one organ.16EBSCO. CA 27-29 test It can be high with ovarian, colon, stomach, kidney, lung, pancreatic, uterine, and liver cancers.17EBSCO. CA 27-29 test Cervical cancer is also listed.18PubMed Central. Hypermetabolic Pulmonary and Mediastinal Lesions With Elevated Cancer Antigen (CA) 15-3 and CA 27-29 in a Patient With a History of Ovarian and Breast Cancer
Non-cancer causes are just as varied. Chronic hepatitis and cirrhosis can raise it.19PubMed Central. Hypermetabolic Pulmonary and Mediastinal Lesions With Elevated Cancer Antigen (CA) 15-3 and CA 27-29 in a Patient With a History of Ovarian and Breast Cancer So can tuberculosis, lupus, and sarcoidosis, an inflammatory condition that often affects the lungs.20PubMed Central. Hypermetabolic Pulmonary and Mediastinal Lesions With Elevated Cancer Antigen (CA) 15-3 and CA 27-29 in a Patient With a History of Ovarian and Breast Cancer Benign breast, liver, and kidney disorders can raise it as well.21PubMed Central. Altered Glycosylation in Tumours Focused to Cancer Diagnosis Some infections can raise it temporarily.22DiviTum® TKa. What is CA 27.29? Pregnancy, especially the first trimester, and breastfeeding can push it above normal in healthy women.23DiviTum® TKa. What is CA 27.29? Endometriosis and benign ovarian conditions are linked to higher levels too.24Kantesti. What Is Considered a High CA 27-29 Level?
The marker is a protein found on the surface of many gland-lining cells, and not only in the breast, so damage or growth in those tissues can release it into the blood. Inflammation and scarring in organs such as the liver and lungs can shed the protein as well, which is why long-term conditions can keep it elevated without any cancer. The test measures the protein and cannot tell which organ or condition it came from, so it cannot separate cancer from these other causes.
In one reported case, scarring lung disease kept a breast cancer survivor’s marker high more than 5 years after diagnosis.25PubMed Central. Normalization of Elevated Tumor Marker CA27-29 After Bilateral Lung Transplantation in a Patient With Breast Cancer and Idiopathic Pulmonary Fibrosis It led to extensive testing and nearly cost her a lung transplant spot, and her levels returned to normal after the transplant.26PubMed Central. Normalization of Elevated Tumor Marker CA27-29 After Bilateral Lung Transplantation in a Patient With Breast Cancer and Idiopathic Pulmonary Fibrosis A high number without a clear cause can drive a great deal of testing, which is why the full health picture matters.
So tell your doctor what else is going on: pregnancy, breastfeeding, or a recent infection; known liver problems or hepatitis; lung or autoimmune conditions like lupus. Any of these can explain a high result without cancer.
For someone with a long-term condition like liver disease, a mildly raised marker may be a stable baseline that never changes, and doctors read a rise from that baseline. If scans and examination are clear and the number stays steady, doctors may conclude the other condition is responsible and stop chasing the result.
Why the Trend Matters More Than One Result
A sustained rise across two or more comparable tests is more useful than a single high reading.27Kantesti AI. What Is Considered a High CA 27-29 Level? Doctors look at direction, speed of change, timing with treatment, and whether the change is bigger than normal test variation.28Kantesti AI. What Is Considered a High CA 27-29 Level? Results can go up and down over time for different reasons.29City of Hope. CA 27.29
In practice, doctors compare results taken at the same lab with the same method, since mixing methods can create apparent changes. A steady climb across several tests is read differently from a single spike that falls back on the next test. Small bumps within the test’s own variation are usually treated as noise, so a change has to be large enough to stand out from that background. Speed counts too: a slow drift over a year suggests something different from a doubling in a few weeks.
In one research study, a rise of 75% or more above a person’s starting level was treated as abnormal.30PubMed Central. The SURVIVE study (NCT05658172): Bringing breast cancer aftercare to the 21stcentury: Study protocol of a Phase III clinical trial comparing liquid biopsy guided vs. Standard of care surveillance for intermediate to high-risk breast cancer survivors That is a cutoff used in one study, not a universal rule for every person or clinic. Your doctor decides what change is meaningful for you, based on your starting level, the lab, your treatment and your symptoms. Asking what size of change would concern them is more useful than applying a percentage from a paper.
During treatment, this marker tracked how the disease was actually doing in about 8 in 10 people.31PubMed. Comparison of CEA, MCA, CA 15-3 and CA 27-29 in follow-up and monitoring therapeutic response in breast cancer patients For someone with known spread, falling values after a treatment starts are encouraging and suggest it is working, though scans and symptoms are checked too. In the other 2 in 10, the marker didn’t match, and scans decide. A number that is flat or only slowly rising may lead to a conversation about whether to continue, change or add to treatment.
A tumor flare is a short-lived rise in symptoms and markers after starting hormone treatment.32MedDocs Publishers LLC. Bone Marrow Only Metastases from Lobular Carcinoma: Insights into Responses to Endocrine Therapy In one reported case the marker jumped after a treatment change, then fell by over two thirds about two weeks later.33MedDocs Publishers LLC. Bone Marrow Only Metastases from Lobular Carcinoma: Insights into Responses to Endocrine Therapy A rise right after starting new treatment isn’t automatically bad news.
The most common misreading is treating one jump as proof of progression. A repeat test is often the next step, and stable or falling numbers over months are reassuring.
It helps to keep your own record: note each date, value and lab, with treatment changes beside each result. Ask your doctor what change would concern them.
CA 27-29 Versus CA 15-3
Both tests measure parts of the same protein, and they use different antibodies that recognize slightly different parts of it. That overlap is why they usually move together: they agreed on normal versus high in about 94% of paired tests.34PubMed. Concordance analysis of paired cancer antigen (CA) 15-3 and 27.29 testing When they disagreed, CA 27-29 was the one flagged high about 3 in 4 times.35American Journal of Clinical Pathology. Comparison of Breast Cancer Tumor Marker Test Results: A Retrospective Analysis of Paired CA 15-3 and CA 27.29 Testing at a National Reference Laboratory Their changes over time matched in about 9 in 10 cases when doubling or halving.36PubMed. Concordance analysis of paired cancer antigen (CA) 15-3 and 27.29 testing
They are still separate tests with separate cutoffs, so the numbers themselves are not interchangeable. A flagged CA 27-29 beside a normal CA 15-3 is not unusual and not alarming on its own. The difference may reflect how each assay detects the protein, not a hidden disease. A single mismatch is a reason for your doctor to repeat the test or follow the trend, not to conclude something is wrong.
Switching tests can make a result look different without any real change, so stick with one. If a clinic changes from one test to the other, the new number starts a fresh series with its own scale and cutoff. A jump from a normal CA 15-3 to a flagged CA 27-29 may come only from the change in tests. Staying with one test at one lab lets each result be compared directly with the last.
If your doctor orders both, expect the numbers to differ and watch each test’s own trend. Ask before comparing a value from one with the other.
Why Some Doctors Don’t Order This Test
ASCO advises against routine CA 27-29 tests to watch for return after first breast cancer treatment.37Journal of Clinical Oncology. 2007 Update of ASCO Recommendations for the Use of Tumor Markers in Breast Cancer Routine scans and tumor markers aren’t recommended for people with no symptoms and a normal exam.38PubMed. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update The test is still used to track whether spread cancer is responding to treatment.39Mayo Clinic Laboratories. Breast Carcinoma-Associated Antigen, Serum
The reasoning is practical. In someone without symptoms, a marker rise may lead to scans and worry without showing that finding spread earlier improves how long people live. False alarms are possible because many non-cancer conditions raise the marker, which can lead to extra tests and anxiety. A normal marker can also falsely reassure, since some cancers don’t raise it. The guidance is about routine checking in people who feel well and have normal exams, not about people with symptoms or known spread.
When cancer has already spread, doctors need ways to see whether treatment is working between scans, and a marker that tracks the disease can help. A falling number supports continuing treatment, while a rising one may lead to scans or a change of plan. Even then, the marker is read with imaging and how you feel, not alone.
Worrying while waiting for results is normal, and results are only one part of the picture.40City of Hope. CA 27.29 Rarely, substances in a blood sample can distort the result.41Kantesti AI. What Is Considered a High CA 27-29 Level? A result that clashes with stable scans and good health may warrant a repeat or a different lab method.42Kantesti AI. What Is Considered a High CA 27-29 Level? After a high result, follow-up usually means a repeat test in a few weeks, possibly imaging such as CT or bone scans, and a review of other conditions and medicines.
Useful questions for your doctor: Why is this test being ordered for me? What would make you act on a result? Should repeat tests be done at the same lab? What symptoms should I report regardless of the number?